Study of lavender essential oil encapsulated chitosan-derivative nanoparticles on shampoo applications

Since lavender essential oil (LEO) contains antibacterial, antiinflammatory, and calming qualities, it is commonly utilized in hair care products. However, adding LEO conventionally results in quick evaporation and a shorter product shelf life due to its high volatility. In this study, chitosan-derivative nanoparticles (CSNPs) were initially prepared by degradation, modification, and purification. LEO was then encapsulated to create LEO-CSNPs, and FTIR, DLS, TEM, and 'H-NMR were used to evaluate both CSNPs and LEO-CSNPs. The effectiveness of the shampoos was next assessed by clinical trials and in vitro tests, such as malassezia inhibition, sebocyte lipid secretion, DPPH radical scavenging as well as qPCR for inflammatory markers with varying concentrations of LEO-CSNPs. The findings confirmed successful encapsulation since LEO-CSNPs (352.27 nm) had a higher particle size than CSNPs (218 nm). With a 15.5 mm Malassezia inhibition zone, 87.71% sebocyte lipid inhibition, 79.03% DPPH scavenging rate, and a notable downregulation of IL-6 and IL-8 expression. Meanwhile, the 0.5% LEO-CSNPs group demonstrated concentration-dependent efficacy. In terms of clinical results, fragrance longevity was increased to 7.2 hours, scalp flaking was decreased by 77.73%, and itching was also decreased by 69.05%. In conclusion, encapsulating LEO in chitosan-derived nanoparticles resolved its volatility problem and improved the antifungal, sebum-regulating, antioxidant, and anti-inflammatory properties in shampoo. Finally, the ideal concentration of LEO-CSNPs is between 0.3% and 0.5%, laying the groundwork for multipurpose shampoo.

Authors

Publication Details

Journal
Springer Link (Chiba Institute of Technology)
Published
2026-04-24
DOI
https://doi.org/10.1051/bioconf/202623203002/pdf
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of lavender essential oil encapsulated chitosan-derivative nanoparticles on shampoo applications

Jumao Yuan, Wanyue Zeng
Springer Link (Chiba Institute of Technology)
Advancements in Transdermal Drug Delivery
article

Study of lavender essential oil encapsulated chitosan-derivative nanoparticles on shampoo applications

Jumao Yuan, Wanyue Zeng
article en

Abstract

Since lavender essential oil (LEO) contains antibacterial, antiinflammatory, and calming qualities, it is commonly utilized in hair care products. However, adding LEO conventionally results in quick evaporation and a shorter product shelf life due to its high volatility. In this study, chitosan-derivative nanoparticles (CSNPs) were initially prepared by degradation, modification, and purification. LEO was then encapsulated to create LEO-CSNPs, and FTIR, DLS, TEM, and 'H-NMR were used to evaluate both CSNPs and LEO-CSNPs. The effectiveness of the shampoos was next assessed by clinical trials and in vitro tests, such as malassezia inhibition, sebocyte lipid secretion, DPPH radical scavenging as well as qPCR for inflammatory markers with varying concentrations of LEO-CSNPs. The findings confirmed successful encapsulation since LEO-CSNPs (352.27 nm) had a higher particle size than CSNPs (218 nm). With a 15.5 mm Malassezia inhibition zone, 87.71% sebocyte lipid inhibition, 79.03% DPPH scavenging rate, and a notable downregulation of IL-6 and IL-8 expression. Meanwhile, the 0.5% LEO-CSNPs group demonstrated concentration-dependent efficacy. In terms of clinical results, fragrance longevity was increased to 7.2 hours, scalp flaking was decreased by 77.73%, and itching was also decreased by 69.05%. In conclusion, encapsulating LEO in chitosan-derived nanoparticles resolved its volatility problem and improved the antifungal, sebum-regulating, antioxidant, and anti-inflammatory properties in shampoo. Finally, the ideal concentration of LEO-CSNPs is between 0.3% and 0.5%, laying the groundwork for multipurpose shampoo.

Springer Link (Chiba Institute of Technology)
Openalex Percentile: Top 7%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.